Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Provention Bio Announces Top-Line Results from its PRV-300 Trial

americanpharmaceuticalreviewMay 10, 2019

Tag: PRV-300 , trial , Provention , BIO , anti-TLR3

PharmaSources Customer Service